Rarity of silent progression: PIRA and RAW in myelin oligodendrocyte glycoprotein antibody–associated disease
Published online on January 14, 2026
Abstract
Multiple Sclerosis Journal, Ahead of Print.
In myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), disability is typically attack-related and frequently remain stable over time if no relapses occur. This retrospective cohort study assessed the prevalence of progression ...
In myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), disability is typically attack-related and frequently remain stable over time if no relapses occur. This retrospective cohort study assessed the prevalence of progression ...